Oramed Pharmaceuticals, Inc. (ORMP)
4.71
+0.15
(+3.29%)
USD |
NASDAQ |
May 14, 16:00
4.71
0.00 (0.00%)
After-Hours: 20:00
Oramed Pharmaceuticals EPS Diluted (Quarterly) : 0.2274 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 1.308 |
| Eli Lilly & Co. | 8.255 |
| Merck & Co., Inc. | -1.715 |
| Pfizer Inc. | 0.4688 |
| SIGA Technologies, Inc. | -0.0482 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 9.201M |
| Total Expenses (Quarterly) | -9.201M |
| Enterprise Value | 59.37M |
| Earnings Yield | 31.54% |
| Normalized Earnings Yield | 16.15 |